Citadel Advisors’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-2,800
| Closed | -$221K | – | 14018 |
|
|
2020
Q4 | $221K | Sell |
2,800
-7,300
| -72% | -$428K | ﹤0.01% | 9593 |
|
|
2020
Q3 | $444K | Sell |
10,100
-300
| -3% | -$14.8K | ﹤0.01% | 7498 |
|
|
2020
Q2 | $460K | Buy |
10,400
+2,300
| +28% | +$85.8K | ﹤0.01% | 7235 |
|
|
2020
Q1 | $291K | Sell |
8,100
-1,600
| -16% | -$91K | ﹤0.01% | 7396 |
|
|
2019
Q4 | $688K | Sell |
9,700
-3,100
| -24% | -$225K | ﹤0.01% | 6284 |
|
|
2019
Q3 | $957K | Buy |
+12,800
| New | +$1.09M | ﹤0.01% | 5674 |
|
|
2019
Q2 | – | Sell |
-3,600
| Closed | -$241K | – | 10157 |
|
|
2019
Q1 | $241K | Buy |
+3,600
| New | +$273K | ﹤0.01% | 7934 |
|
|
2018
Q4 | – | Sell |
-11,100
| Closed | -$1.02M | – | 10054 |
|
|
2018
Q3 | $1.02M | Sell |
11,100
-1,300
| -10% | -$124K | ﹤0.01% | 5503 |
|
|
2018
Q2 | $1.22M | Buy |
+12,400
| New | +$1.39M | ﹤0.01% | 4874 |
|
|
2018
Q1 | – | Sell |
-3,800
| Closed | -$391K | – | 9003 |
|
|
2017
Q4 | $391K | Sell |
3,800
-2,600
| -41% | -$259K | ﹤0.01% | 6038 |
|
|
2017
Q3 | $603K | Buy |
+6,400
| New | +$505K | ﹤0.01% | 5040 |
|
|
2017
Q2 | – | Sell |
-7,100
| Closed | -$569K | – | 8301 |
|
|
2017
Q1 | $569K | Buy |
+7,100
| New | +$564K | ﹤0.01% | 4810 |
|
|
2016
Q1 | – | Sell |
-600
| Closed | -$37K | – | 8450 |
|
|
2015
Q4 | $37K | Buy |
+600
| New | +$36.6K | ﹤0.01% | 7531 |
|
|
2015
Q2 | – | Sell |
-100
| Closed | -$5K | – | 9244 |
|
|
2015
Q1 | $5K | Hold |
100
| – | – | ﹤0.01% | 8332 |
|
|
2014
Q4 | $4K | Buy |
+100
| New | +$4.08K | ﹤0.01% | 8315 |
|
|
2014
Q3 | – | Sell |
-200
| Closed | -$7K | – | 8532 |
|
|
2014
Q2 | $7K | Sell |
200
-900
| -82% | -$30.5K | ﹤0.01% | 7675 |
|
|
2014
Q1 | $37K | Buy |
1,100
+400
| +57% | +$13.2K | ﹤0.01% | 6967 |
|
|
2013
Q4 | $24K | Sell |
700
-5,150
| -88% | -$178K | ﹤0.01% | 6376 |
|
|
2013
Q3 | $186K | Buy |
+5,850
| New | +$156K | ﹤0.01% | 4834 |
|
Citadel Advisors's CMD Position: Q2 2021 in Review
Citadel Advisors sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 1,031,759 shares — an estimated $82.4M sold.
Citadel Advisors first reported a position in CMD in Q3 2013 and held it in 25 quarters. The position peaked at $82.4M in Q1 2021. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Citadel Advisors reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Citadel Advisors sold 1,031,759 Cantel Medical Corporation shares in Q2 2021, an estimated $82.4M.
- Citadel Advisors first reported a position in Cantel Medical Corporation in Q3 2013 and held it in 25 quarters.
- Citadel Advisors's Cantel Medical Corporation position peaked at $82.4M in Q1 2021.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.